- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 121.54M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $409.16M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $403.79M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $150K |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $4.51M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $24.1M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $65.9M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $167.64M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$52.42M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$43.23M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $73.07M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $414.16M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $834.33M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $857.19M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $111.37M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $365.13M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $802.28M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $813.97M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 97.51M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $41K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $8.47M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.14 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.14 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $25.51M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$13.36M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$34.67M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $37.08M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $78.37M |
| Revenue | Q1 2025 · Mar 31, 2024 | $84.42M |